Ford Street Ventures

Impruvon Health develops a medical technology platform for automated medication management designed for individuals who have difficulty maintaining regimens at home or in long-term care, and for the people who support them. The platform is tailored for groups such as those with intellectual or developmental disabilities, individuals recovering from addiction, and veterans. It automates storage, administration, and record keeping to reduce errors and enhance independence and security for patients. It uses smart alerts, reminders, and live alerts of unauthorized access to help healthcare providers keep medications from being misused or diverted. It addresses the impact of medication errors on patients and families and aims to stop errors, thefts, and overdoses while improving compliance and safety for patients and caregivers.

Aerodome develops advanced drone technology designed specifically for public safety agencies. Their automated, remote-controlled drone systems enable faster response times in search and rescue, disaster response, and law enforcement missions, reducing the need for patrol officers to attend calls.

Persist AI is a company that aids pharmaceutical firms in the development of long-acting drug formulations by leveraging artificial intelligence and automation. Traditional formulation development is a lengthy process, typically spanning 5 to 10 years, which includes extensive pre-clinical and clinical testing phases. Persist AI aims to significantly reduce this timeline by streamlining pre-clinical formulation development to just three months, enhancing the efficiency of the drug development process by 50%. The company employs AI-driven automation technologies, such as automated drug release testing and high-throughput formulation screening, to facilitate quicker and more reliable drug formulation. By doing so, Persist AI not only accelerates drug development but also contributes to improving patient outcomes.